Intermittent Claudication Market By Drug Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Intermittent Claudication Market
Intermittent Claudication Market: By Drug Type (ALD-301, DVC1-0101, K-134, LT-0101, PLX-PAD, Tirasemtiv), By Treatment Process (Medication therapies, Revascularization) and Geography - Forecast(2018 - 2023)
Report Code : HCR 0229
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Intermittent Claudication – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Intermittent Claudication – Market Forces
   4.1. Drivers
      4.1.1. Increasing population with life style, smoking, hypertension, diabetes and high cholesterol related diseases
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Intermittent Claudication – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Intermittent Claudication  Market, By Drug Type
   6.1. ALD-301
   6.2. DVC1-0101
   6.3. K-134
   6.4. LT-0101
   6.5. PLX-PAD
   6.6. Tirasemtiv
7. Intermittent Claudication  Market, By Treatment Process
   7.1. Medication therapies
   7.2. Revascularization
8. Intermittent Claudication  Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Intermittent Claudication – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   10.1. Cytokinetics Inc.
   10.2. DNAVEC Corporation
   10.3. Nuo Therapeutics Inc.
   10.4. Kowa Company Ltd.
   10.5. LTT Bio-Pharma Co. Ltd.
   10.6. Pluristem Therapeutics Inc.
   10.7. ID Pharma Co., Ltd.
   10.8. Bayer AG
   10.9. Cipla Inc.
   10.10. Cadila Pharmaceuticals Ltd.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Intermittent claudication can be defined as muscle pain (ache, cramp, numbness or sense of fatigue) especially in calf muscle during exercise, such as walking, and is relieved by a short period of rest due to lack of blood supply. Claudication is usually diagnosed in people suffering from peripheral arterial disease (PAD), which is usually caused due to artherosclerosis due to hardening of arteries due to deposition of cholesterol in the inner lining of the arteries. Globally increasing cases of PAD and increasing awareness about intermittent claudication is expected to be prime growth driver for the intermittent claudication market.

This report identifies the intermittent claudication market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to intermittent claudication market.
 
Intermittent Clauication Market

Globally North America dominated the market for intermittent claudication in 2015 with highest market share due to higher number of people suffering from PAD mostly individuals older than 60 years of age. Additionally, aging population is also considered as one of the key factor propelling the growth of this market and developed medical and healthcare establishment in the region is also amongst the major factor responsible for higher market share of the North American market. North America was followed by Europe and Asia as the second and third largest regional market respectively, for intermittent claudication. However, Asia-Pacific is expected to be fastest growing regional segment during the period of study due to fast growing healthcare setup in the region especially in India and China along with growing awareness about the intermittent claudication therapy in the region.
  • This report on global intermittent claudication covers different type of drugs available for intermittent claudication also classifies the global intermittent claudication market based on the treatment process, and market size in various geographical regions.
  • On the basis of types of drugs available for intermittent claudication, this report is segmented into six major segments as follows: ALD-301, DVC1-0101, K-134, LT-0101, PLX-PAD, and Tirasemtiv)
  •  This reports is also classified on the basis of treatment process for intermittent claudication, based on this global intermittent claudication market is classified into two major segments as follows: Medication therapies, and Revascularization
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for intermittent claudication  in each of the region.

This report identifies all the major companies operating in the global intermittent claudication market. Some of the major companies’ profiles in detail are as follows:
  • DNAVEC Corporation
  • Nuo Therapeutics Inc.
  • Kowa Company Ltd.
  • LTT Bio-Pharma Co. Ltd.
  • Pluristem Therapeutics Inc.
List of Tables:

Table 1 Intermittent Claudication Market Overview 2017-2023
Table 2 Intermittent Claudication Market Leader Analysis 2017-2018 (US$)
Table 3 Intermittent Claudication Market Product Analysis 2017-2018 (US$)
Table 4 Intermittent Claudication Market End User Analysis 2017-2018 (US$)
Table 5 Intermittent Claudication Market Patent Analysis 2013-2018* (US$)
Table 6 Intermittent Claudication Market Financial Analysis 2017-2018 (US$)
Table 7 Intermittent Claudication Market Driver Analysis 2017-2018 (US$)
Table 8 Intermittent Claudication Market Challenges Analysis 2017-2018 (US$)
Table 9 Intermittent Claudication Market Constraint Analysis 2017-2018 (US$)
Table 10 Intermittent Claudication Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11 Intermittent Claudication Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12 Intermittent Claudication Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13 Intermittent Claudication Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14 Intermittent Claudication Market Degree of Competition Analysis 2017-2018 (US$)
Table 15 Intermittent Claudication Market Value Chain Analysis 2017-2018 (US$)
Table 16 Intermittent Claudication Market Pricing Analysis 2018-2023 (US$)
Table 17 Intermittent Claudication Market Opportunities Analysis 2018-2023 (US$)
Table 18 Intermittent Claudication Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19 Intermittent Claudication Market Supplier Analysis 2017-2018 (US$)
Table 20 Intermittent Claudication Market Distributor Analysis 2017-2018 (US$)
Table 21 Intermittent Claudication Market Trend Analysis 2017-2018 (US$)
Table 22 Intermittent Claudication Market Size 2017 (US$)
Table 23 Intermittent Claudication Market Forecast Analysis 2018-2023 (US$)
Table 24 Intermittent Claudication Market Sales Forecast Analysis 2018-2023 (Units)
Table 25 Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 26 Intermittent Claudication Market By Drug Type, Revenue & Volume, By ALD-301, 2018-2023 ($)
Table 27 Intermittent Claudication Market By Drug Type, Revenue & Volume, By DVC1-0101, 2018-2023 ($)
Table 28 Intermittent Claudication Market By Drug Type, Revenue & Volume, By K-134, 2018-2023 ($)
Table 29 Intermittent Claudication Market By Drug Type, Revenue & Volume, By LT-0101, 2018-2023 ($)
Table 30 Intermittent Claudication Market By Drug Type, Revenue & Volume, By PLX-PAD, 2018-2023 ($)
Table 31 Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 32 Intermittent Claudication Market By Treatment Process, Revenue & Volume, By Medication therapies, 2018-2023 ($)
Table 33 Intermittent Claudication Market By Treatment Process, Revenue & Volume, By Revascularization, 2018-2023 ($)
Table 34 North America Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 35 North America Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 36 South america Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 37 South america Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 38 Europe Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 39 Europe Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 40 APAC Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 41 APAC Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 42 Middle East & Africa Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 43 Middle East & Africa Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 44 Russia Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 45 Russia Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 46 Israel Intermittent Claudication Market, Revenue & Volume, By Drug Type, 2018-2023 ($)
Table 47 Israel Intermittent Claudication Market, Revenue & Volume, By Treatment Process, 2018-2023 ($)
Table 48 Top Companies 2017 (US$)Intermittent Claudication Market, Revenue & Volume
Table 49 Product Launch 2017-2018Intermittent Claudication Market, Revenue & Volume
Table 50 Mergers & Acquistions 2017-2018Intermittent Claudication Market, Revenue & Volume


List of Figures:

Figure 1 Overview of Intermittent Claudication Market 2017-2023
Figure 2 Market Share Analysis for Intermittent Claudication Market 2017 (US$)
Figure 3 Product Comparison in Intermittent Claudication Market 2017-2018 (US$)
Figure 4 End User Profile for Intermittent Claudication Market 2017-2018 (US$)
Figure 5 Patent Application and Grant in Intermittent Claudication Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Intermittent Claudication Market 2017-2018 (US$)
Figure 7 Market Entry Strategy in Intermittent Claudication Market 2017-2018
Figure 8 Ecosystem Analysis in Intermittent Claudication Market 2017
Figure 9 Average Selling Price in Intermittent Claudication Market 2017-2023
Figure 10 Top Opportunites in Intermittent Claudication Market 2017-2018
Figure 11 Market Life Cycle Analysis in Intermittent Claudication Market Market Life Cycle Analysis in 3D Printing
Figure 12 GlobalBy Drug TypeIntermittent Claudication Market Revenue, 2018-2023 ($)
Figure 13 GlobalBy Treatment ProcessIntermittent Claudication Market Revenue, 2018-2023 ($)
Figure 14 Global Intermittent Claudication Market - By Geography
Figure 15 Global Intermittent Claudication Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 16 Global Intermittent Claudication Market CAGR, By Geography, 2018-2023 (%)
Figure 17 North America Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 18 US Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 19 US GDP and Population, 2017-2018 ($)
Figure 20 US GDP – Composition of 2017, By Sector of Origin
Figure 21 US Export and Import Value & Volume, 2017-2018 ($)
Figure 22 Canada Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 23 Canada GDP and Population, 2017-2018 ($)
Figure 24 Canada GDP – Composition of 2017, By Sector of Origin
Figure 25 Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26 Mexico Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 27 Mexico GDP and Population, 2017-2018 ($)
Figure 28 Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29 Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30 South America Intermittent Claudication Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31 Brazil Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 32 Brazil GDP and Population, 2017-2018 ($)
Figure 33 Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34 Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35 Venezuela Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 36 Venezuela GDP and Population, 2017-2018 ($)
Figure 37 Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38 Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39 Argentina Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 40 Argentina GDP and Population, 2017-2018 ($)
Figure 41 Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42 Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43 Ecuador Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 44 Ecuador GDP and Population, 2017-2018 ($)
Figure 45 Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46 Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47 Peru Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 48 Peru GDP and Population, 2017-2018 ($)
Figure 49 Peru GDP – Composition of 2017, By Sector of Origin
Figure 50 Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51 Colombia Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 52 Colombia GDP and Population, 2017-2018 ($)
Figure 53 Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54 Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55 Costa Rica Intermittent Claudication Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56 Costa Rica GDP and Population, 2017-2018 ($)
Figure 57 Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58 Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59 Europe Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 60 U.K Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 61 U.K GDP and Population, 2017-2018 ($)
Figure 62 U.K GDP – Composition of 2017, By Sector of Origin
Figure 63 U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64 Germany Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 65 Germany GDP and Population, 2017-2018 ($)
Figure 66 Germany GDP – Composition of 2017, By Sector of Origin
Figure 67 Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68 Italy Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 69 Italy GDP and Population, 2017-2018 ($)
Figure 70 Italy GDP – Composition of 2017, By Sector of Origin
Figure 71 Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72 France Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 73 France GDP and Population, 2017-2018 ($)
Figure 74 France GDP – Composition of 2017, By Sector of Origin
Figure 75 France Export and Import Value & Volume, 2017-2018 ($)
Figure 76 Netherlands Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 77 Netherlands GDP and Population, 2017-2018 ($)
Figure 78 Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79 Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80 Belgium Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 81 Belgium GDP and Population, 2017-2018 ($)
Figure 82 Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83 Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84 Spain Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 85 Spain GDP and Population, 2017-2018 ($)
Figure 86 Spain GDP – Composition of 2017, By Sector of Origin
Figure 87 Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88 Denmark Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 89 Denmark GDP and Population, 2017-2018 ($)
Figure 90 Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91 Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92 APAC Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 93 China Intermittent Claudication Market Value & Volume, 2018-2023
Figure 94 China GDP and Population, 2017-2018 ($)
Figure 95 China GDP – Composition of 2017, By Sector of Origin
Figure 96 China Export and Import Value & Volume, 2017-2018 ($)Intermittent Claudication Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 97 Australia Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 98 Australia GDP and Population, 2017-2018 ($)
Figure 99 Australia GDP – Composition of 2017, By Sector of Origin
Figure 100 Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101 South Korea Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 102 South Korea GDP and Population, 2017-2018 ($)
Figure 103 South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104 South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105 India Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 106 India GDP and Population, 2017-2018 ($)
Figure 107 India GDP – Composition of 2017, By Sector of Origin
Figure 108 India Export and Import Value & Volume, 2017-2018 ($)
Figure 109 Taiwan Intermittent Claudication Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110 Taiwan GDP and Population, 2017-2018 ($)
Figure 111 Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112 Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113 Malaysia Intermittent Claudication Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114 Malaysia GDP and Population, 2017-2018 ($)
Figure 115 Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116 Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117 Hong Kong Intermittent Claudication Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118 Hong Kong GDP and Population, 2017-2018 ($)
Figure 119 Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120 Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121 Middle East & Africa Intermittent Claudication Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122 Russia Intermittent Claudication Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123 Russia GDP and Population, 2017-2018 ($)
Figure 124 Russia GDP – Composition of 2017, By Sector of Origin
Figure 125 Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126 Israel Intermittent Claudication Market Value & Volume, 2018-2023 ($)
Figure 127 Israel GDP and Population, 2017-2018 ($)
Figure 128 Israel GDP – Composition of 2017, By Sector of Origin
Figure 129 Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130 Entropy Share, By Strategies, 2017-2018* (%)Intermittent Claudication Market
Figure 131 Developments, 2017-2018*Intermittent Claudication Market
Figure 132 Company 1 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 133 Company 1 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 134 Company 1 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 135 Company 2 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 136 Company 2 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137 Company 2 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 138 Company 3 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 139 Company 3 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140 Company 3 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 141 Company 4 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 142 Company 4 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143 Company 4 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 144 Company 5 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 145 Company 5 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146 Company 5 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 147 Company 6 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 148 Company 6 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149 Company 6 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 150 Company 7 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 151 Company 7 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152 Company 7 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 153 Company 8 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 154 Company 8 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155 Company 8 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 156 Company 9 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 157 Company 9 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158 Company 9 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 159 Company 10 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 160 Company 10 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161 Company 10 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 162 Company 11 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 163 Company 11 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164 Company 11 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 165 Company 12 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 166 Company 12 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167 Company 12 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 168 Company 13 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 169 Company 13 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170 Company 13 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 171 Company 14 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 172 Company 14 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173 Company 14 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Figure 174 Company 15 Intermittent Claudication Market Net Revenue, By Years, 2017-2018* ($)
Figure 175 Company 15 Intermittent Claudication Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176 Company 15 Intermittent Claudication Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll